Jennifer Cote
Known title: Interim CFOCIK: 0001960481
Associated companies
Transaction History
| HBIO | ▼ Sell | Tax Withholding | 5,687 | $4K | 3/19/2025 | View on chart |
| HBIO | ▼ Sell | Tax Withholding | 4,731 | $9K | 12/29/2024 | View on chart |
| HBIO | ▼ Sell | Tax Withholding | 3,797 | $8K | 12/29/2024 | View on chart |
| HBIO | ▼ Sell | Tax Withholding | 9,920 | $41K | 3/6/2024 | View on chart |
| HBIO | ▲ Buy | Grant | 35,800 | $0 | 3/5/2024 | View on chart |
| HBIO | ▲ Buy | Grant | 35,800 | $0 | 3/5/2024 | View on chart |
| HBIO | ▼ Sell | Tax Withholding | 3,279 | $18K | 12/29/2023 | View on chart |
| HBIO | ▼ Sell | Tax Withholding | 2,631 | $14K | 12/29/2023 | View on chart |
| HBIO | ▲ Buy | Grant | 26,892 | $0 | 3/6/2023 | View on chart |
| HBIO | ▲ Buy | Grant | 25,862 | $0 | 3/6/2023 | View on chart |
| HBIO | ▲ Buy | Grant | 29,880 | $0 | 3/6/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Harvard Bioscience Forms Scientific Advisory Board
Harvard Bioscience announced the creation of a Scientific Advisory Board. This move is intended to support the company's scientific direction and product development. The stock is currently trading with a high beta, indicating higher volatility relative to the broader market.
Harvard Bioscience Forms Scientific Advisory Board. Harvard Bioscience announced the creation of a Scientific Advisory Board. This move is intended to support the company's scientific direction and product development. The stock is currently trading with a high beta, indicating higher volatility relative to the broader market.